Clinical Nuclear Medicine

Skip Navigation LinksHome > September 2012 - Volume 37 - Issue 9 > Superscan-like Hypermetabolic Lesions on Delayed FDG PET/CT...
Clinical Nuclear Medicine:
doi: 10.1097/RLU.0b013e31825b23d5
Interesting Images

Superscan-like Hypermetabolic Lesions on Delayed FDG PET/CT Imaging in a Patient With Lung Cancer

Cheng, Gang MD, PhD*; Alavi, Abass MD (Hon), PhD (Hon), DSc (Hon); Lim, Esther MD*; Akers, Scott R. MD, PhD*

Free Access
Article Outline
Collapse Box

Author Information

From the *Department of Radiology, Philadelphia VA Medical Center; and †Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA.

Received for publication January 31, 2012; revision accepted March 6, 2012.

Conflicts of interest and sources of funding: none declared.

Reprints: Scott R. Akers, MD, PhD, Department of Radiology, Philadelphia VA Medical Center, 3900 Woodland Ave, Philadelphia, PA 19104. E-mail:

Collapse Box


Abstract: A 69-year-old man with a lung mass underwent multiple-time-point FDG PET/CT imaging for diagnostic evaluation. The initial PET imaging (performed at 1 hour after tracer injection) revealed equivocal bone marrow uptake in the right iliac bone and proximal femurs in addition to lung and mediastinal lesions. The 3-hour delayed PET imaging, however, demonstrated widespread bone marrow metastases. Biopsies of the right lung mass and right iliac bone marrow were later performed and revealed a poorly differentiated squamous cell carcinoma in both sites. This case indicates the value of delayed FDG PET in detecting superscan-like hypermetabolic bone marrow lesions in patients with lung cancer.

Back to Top | Article Outline


Figure 1
Figure 1
Image Tools
1. Constable AR, Cranage RW. Recognition of the superscan in prostatic bone scintigraphy. Br J Radiol. 1981; 54: 122–125.

2. Buckley O, O’Keeffe S, Geoghegan T, et al.. 99mTc bone scintigraphy superscans: a review. Nucl Med Commun. 2007; 28: 521–527.

3. Kim D-W, Kim CG, Park S-A, et al.. Metabolic super scan in F-FDG PET/CT imaging. J Korean Med Sc. 2010; 25: 1256–1257.

4. Basu S, Alavi A. Bone marrow and not bone is the primary site for skeletal metastasis: critical role of [18F]fluorodeoxyglucose positron emission tomography in this setting. J Clin Oncol. 2007; 25: 1297.

5. Zhuang H, Pourdehnad M, Lambright ES, et al.. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med. 2001; 42: 1412–1417.

6. Alkhawaldeh K, Bural G, Kumar R, et al.. Impact of dual-time-point (18)F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules. Eur J Nucl Med Mol Imag. 2008; 35: 246–252.

7. Kumar R, Loving VA, Chauhan A, et al.. Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET. J Nucl Med. 2005; 46: 1819–1824.

8. Mavi A, Basu S, Cermik TF, et al.. Potential of dual time point FDG-PET imaging in differentiating malignant from benign pleural disease. Mol Imaging Biol. 2009; 11: 369–378.

9. Xiu Y, Bhutani C, Dhurairaj T, et al.. Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity. Clin Nucl Med. 2007; 32: 101–105.


FDG PET/CT; superscan; bone marrow metastasis; lung cancer

© 2012 Lippincott Williams & Wilkins, Inc.


Article Tools



Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.